Posted by Michael Wonder on 24 Jun 2021
Teva announces Ministry of Health, Labour and Welfare approves Ajovy (fremanezumab) injection in Japan for the preventive treatment of migraine in adults
23 June 2021 - Ajovy developed by Otsuka in Japan through exclusive license agreement.
Teva Pharmaceutical Industries today announced the Ministry of Health, Labour and Welfare has approved the use of Ajovy (fremanezumab) injection for the preventive treatment of migraine in adults in Japan.
